... TrzaskomaB, Sundin D: Use of an integrated clinical trial database to eval-uate the effect of timing of drotrecogin alfa (activated) treat-ment in severe sepsis. Crit Care 2006, 10:R74.28. Kanji S, ... 'stable', and may wait a significant amount of time in order to determine a 'clear' increased or increasing risk of death.On the other hand, because many clinicians increasingly view clinical ... the incidence of severe sepsis is steadily increasing, the total number of deathscontinues to increase [1-3]. In the setting of severe sepsis, early multi-modal, goal-directedtherapy including...